These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34238387)

  • 21. Evaluation of vaccination coverage in cochlear implant patients at a referral hospital in Northern Spain.
    Fernández-Prada M; Madroñal-Menéndez J; Martínez-Ortega C; Ramos-Martín P; Fernández-Noval F; Huerta-González I; Llorente-Pendás JL; Gómez-Martínez JR
    Acta Otorrinolaringol Esp (Engl Ed); 2019; 70(6):336-341. PubMed ID: 30579509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN).
    Chevet B; Figueroa-Parra G; Yang JX; Hulshizer CA; Gunderson TM; Duong SQ; Putman MS; Barbour KE; Crowson CS; Duarte-García A
    J Rheumatol; 2022 Nov; 49(11):1276-1282. PubMed ID: 35777817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus and vaccinations.
    Mathian A; Pha M; Amoura Z
    Curr Opin Rheumatol; 2018 Sep; 30(5):465-470. PubMed ID: 29889693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficiary characteristics and vaccinations in the end-stage renal disease Medicare beneficiary population, an analysis of claims data 2006-2015.
    Shen AK; Kelman JA; Warnock R; Zhang W; Brereton S; McKean S; Wernecke M; Chu S; Gellin BG
    Vaccine; 2017 Dec; 35(52):7302-7308. PubMed ID: 29132990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1007-12. PubMed ID: 15525897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza and pneumococcal vaccine coverages in geriatric health care settings in france.
    Gavazzi G; Wazieres B; Lejeune B; Rothan-Tondeur M
    Gerontology; 2007; 53(6):382-7. PubMed ID: 17622768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice.
    Garg S; Tsagaris K; Cozmuta R; Lipson A
    J Rheumatol; 2018 Dec; 45(12):1656-1662. PubMed ID: 30173154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
    Giese C; Mereckiene J; Danis K; O'Donnell J; O'Flanagan D; Cotter S
    Vaccine; 2016 Jul; 34(32):3657-62. PubMed ID: 27255466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N; Micone P; Gentile A
    Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
    Wyplosz B; Fernandes J; Sultan A; Roche N; Roubille F; Loubet P; Fougère B; Moulin B; Duhot D; Vainchtock A; Raguideau F; Lortet-Tieulent J; Blanc E; Moïsi J; Goussiaume G
    Vaccine; 2022 Aug; 40(33):4911-4921. PubMed ID: 35811205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors for seasonal influenza vaccination and reasons for inadequate vaccination coverage against a broad spectrum of vaccine-preventable diseases: a cross-sectional study among a Brazilian cohort of adult patients with systemic lupus erythematosus.
    Vieira de Rezende RP; Mattos GA; de Mello Leal Augusto R; Machado Gayer CR; Mendes Klumb E
    Lupus; 2019 May; 28(6):794-796. PubMed ID: 31042124
    [No Abstract]   [Full Text] [Related]  

  • 32. Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60.
    Betsch C; Rossmann C; Pletz MW; Vollmar HC; Freytag A; Wichmann O; Hanke R; Hanke W; Heinemeier D; Schmid P; Eitze S; Weber W; Reinhardt A; Küpke NK; Forstner C; Fleischmann-Struzek C; Mikolajetz A; Römhild J; Neufeind J; Rieck T; Suchecka K; Reinhart K
    BMC Public Health; 2018 Jul; 18(1):885. PubMed ID: 30012141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vaccination coverage against influenza and pneumococcus for patients admitted to a pulmonary care service].
    Vandenbos F; Gal J; Radicchi B
    Rev Mal Respir; 2013 Nov; 30(9):746-51. PubMed ID: 24267764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination for influenza and pneumococcus in patients with gastrointestinal cancer or inflammatory bowel disease: A prospective cohort study of methods for improving coverage.
    Sitte J; Frentiu E; Baumann C; Rousseau H; May T; Bronowicki JP; Peyrin-Biroulet L; Lopez A
    Aliment Pharmacol Ther; 2019 Jan; 49(1):84-90. PubMed ID: 30485467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
    Chatham WW; Wallace DJ; Stohl W; Latinis KM; Manzi S; McCune WJ; Tegzová D; McKay JD; Avila-Armengol HE; Utset TO; Zhong ZJ; Hough DR; Freimuth WW; Migone TS;
    J Rheumatol; 2012 Aug; 39(8):1632-40. PubMed ID: 22707609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
    Chi RC; Reiber GE; Neuzil KM
    J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
    Shen AK; Warnock R; Selna W; MaCurdy TE; Chu S; Kelman JA
    Vaccine; 2019 Feb; 37(9):1194-1201. PubMed ID: 30683507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease.
    Saiphoklang N; Phadungwatthanachai J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2102840. PubMed ID: 35943223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suboptimal Immunization Coverage among Canadian Rheumatology Patients in Routine Clinical Care.
    Qendro T; de la Torre ML; Panopalis P; Hazel E; Ward BJ; Colmegna I; Hudson M
    J Rheumatol; 2020 May; 47(5):770-778. PubMed ID: 31308211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
    Nagel J; Saxne T; Geborek P; Bengtsson AA; Jacobsen S; Svaerke Joergensen C; Nilsson JÅ; Skattum L; Jönsen A; Kapetanovic MC
    Lupus; 2017 Sep; 26(10):1072-1081. PubMed ID: 28420056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.